Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics, Inc. is a biopharmaceutical company developing treatments for rare and serious diseases, with a focus on inherited neurological and lysosomal storage disorders that primarily affect children.

Its common stock trades on the Nasdaq market under the ticker PLYX, and a full description of its pipeline and research programs is available in its filings with the U.S. Securities and Exchange Commission.